| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,948,284 |
|
|
Indirect Shares
|
60,990,264 |
|
|
| Direct
Value |
$196,768,173 |
|
|
|
Indirect Value
|
$170,441,288 |
|
|
| Total
Shares |
88,938,548 |
|
|
| Total
Value |
$367,209,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
95
|
|
Stock
price went up :
|
14
|
1
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,834.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-19 |
1,566,956 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-01-23 |
7,594 |
2024-01-23 |
6,955,191 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2023-08-23 |
30,707,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
630 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-12-12 |
4 |
A |
$7.81 |
$185,250 |
D/D |
19,752 |
1,395,209 |
|
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-02-03 |
4/A |
A |
$0.01 |
$16 |
D/D |
1,638 |
3,429,452 |
|
- |
|
| QDEL |
QuidelOrtho Corporation |
officerTitle |
– • – |
2006-02-03 |
4 |
A |
$0.01 |
$16 |
D/D |
1,638 |
3,364,452 |
|
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-03-16 |
4 |
A |
$7.97 |
$1,593,700 |
I/I |
200,000 |
155,933 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-03-17 |
4 |
A |
$7.71 |
$771,360 |
I/I |
100,000 |
189,267 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-01-11 |
4 |
A |
$13.15 |
$6,246,250 |
D/D |
475,000 |
3,142,288 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
8,043,004 |
8,043,004 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2013-08-12 |
4 |
A |
$8.04 |
$5,166,753 |
I/I |
642,631 |
8,685,635 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-05-19 |
4 |
A |
$16.80 |
$14,499,610 |
I/I |
863,072 |
10,639,992 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
208,325 |
1,252,903 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,044,578 |
1,044,578 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-08 |
4 |
A |
$15.01 |
$1,208,305 |
I/I |
80,500 |
1,610,923 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-09 |
4 |
A |
$14.37 |
$280,215 |
I/I |
19,500 |
1,630,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-14 |
4 |
A |
$14.24 |
$284,800 |
I/I |
20,000 |
1,650,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-20 |
4 |
A |
$12.95 |
$323,750 |
I/I |
25,000 |
1,675,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-27 |
4 |
A |
$12.98 |
$129,800 |
I/I |
10,000 |
1,685,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-11-28 |
4 |
A |
$12.95 |
$129,500 |
I/I |
10,000 |
1,695,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-07 |
4 |
A |
$13.97 |
$139,700 |
I/I |
10,000 |
1,705,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-10 |
4 |
A |
$13.89 |
$138,900 |
I/I |
10,000 |
1,715,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-11 |
4 |
A |
$13.83 |
$470,220 |
I/I |
34,000 |
1,749,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-13 |
4 |
A |
$13.23 |
$661,500 |
I/I |
50,000 |
1,799,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-14 |
4 |
A |
$12.86 |
$192,900 |
I/I |
15,000 |
1,814,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-17 |
4 |
A |
$12.37 |
$309,250 |
I/I |
25,000 |
1,839,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-18 |
4 |
A |
$11.86 |
$296,500 |
I/I |
25,000 |
1,864,423 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2018-12-19 |
4 |
A |
$11.21 |
$224,200 |
I/I |
20,000 |
1,884,423 |
0 |
- |
|
630 Records found
|
|
Page 1 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
